ABSTRACT
Purpose
To develop a biomaterial composite for promoting proliferation and migration of neural stem cells (NSCs), as well as angiogenesis on the materials, to rescue central nervous system (CNS) injuries.
Methods
A delivery system was constructed based on cross-linked hyaluronic acid (HA) hydrogels, containing embedded BDNF and VEGF-loaded poly(lactic-co-glycolic acid) (PLGA) microspheres for controlled delivery and support for NSCs in the CNS. The surface morphologies were evaluated by SEM and AFM, mechanical property was investigated by rheological tests, and release kinetics were performed by ELISA. Bioactivity of released BDNF and VEGF was assessed by neuron and endothelial cell culture, respectively. Compatibility with NSCs was studied by immunofluorescent staining.
Results
Release kinetics showed the delivery of BDNF and VEGF from PLGA microspheres and HA hydrogel composite were sustainable and stable, releasing ~20–30% within 150 h. The bioactivities preserved well to promote survival and growth of the cells. Evaluation of structure and mechanical properties showed the hydrogel composite possessed an elastic scaffold structure. Biocompatibility assay showed NSCs adhered and proliferated well on the hydrogel.
Conclusions
Our created HA hydrogel/PLGA microsphere systems have a good potential for controlled delivery of varied biofactors and supporting NSCs for brain repair and implantation.
Similar content being viewed by others
Abbreviations
- BDNF:
-
brain-derived neurotrophic factor
- CNS:
-
central nervous system
- ECM:
-
extracellular matrix
- HA:
-
Hyaluronic acid
- NSC:
-
neural stem cell
- PLGA:
-
poly(lactic-co-glycolic acid)
- VEGF:
-
vascular endothelial growth factor
REFERENCES
Yiu G, He Z. Glial inhibition of CNS axon regeneration. Nat Rev Neurosci. 2006;7:617–27.
Wang KC, Koprivica V, Kim JA, Sivasankaran R, Guo Y, Neve RL, et al. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature. 2002;417:941–4.
Delcroix GJR, Schiller PC, Benoit J-P, Montero-Menei CN. Adult cell therapy for brain neuronal damages and the role of tissue engineering. Biomaterials. 2010;31:2105–20.
Chiara P, Laura L, Gian LB, Cristina R, Carolina F, Ferruccio P, et al. Arterially perfused neurosphere-derived cells distribute outside the ischemic core in a model of transient focal ischemia and reperfusion in vitro. PLoS ONE. 2008;7:1–8.
Rutledge G, Ellis B, Yu XL, Si WY, David KCT, Shu GZ, et al. Nano neuro knitting: Peptide nanofiber scaffold for brain repair and axon regeneration with functional return of vision. Proc Natl Acad Sci. 2006;103(13):5054–9.
Hicks AU, Lappalainen RS, Narkilahti S, Suuronen R, Corbett D, Sivenius J, et al. Transplantation of human embryonic stem cell-derived neural precursor cells and enriched environment after cortical stroke in rats: cell survival and functional recovery. Eur J Neurosci. 2009;29:562–74.
Kazanis I, Lathia J, Moss L, ffrench CC. The neural stem cell microenvironment StemBook, The Stem Cell Research Community; 2008.
Jason MB, Hideki K, Shahin R. Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors. Nat Rev. 2010;10:138–46.
Peter AW, Kevin RA, Fernando J, Shinil KS, Matthew TH, Brijesh SG, et al. Advances in progenitor cell therapy using scaffolding constructs for central nervous system injury. Stem Cell Rev. 2009;5:283–300.
Lauren L, Kevin EH, David S. Engineering biomaterials for synthetic neural stem cell microenvironments. Chem Rev. 2008;108:1787–96.
Hou SP, Xu QY, Tian WM, Cui FZ, Cai Q, Ma J, et al. The repair of brain lesion by implantation of hyaluronic acid hydrogels modified with laminin. J Neurosci Meth. 2005;148(1):60–70.
Tian WM, Zhang CL, Hou SP, Yu X, Cui FZ, Xu QY, et al. Hyaluronic acid hydrogel as Nogo-66 receptor antibody delivery system for the repairing of injured rat brain: in vitro. J Control Release. 2005;102(1):13–22.
Hou SP, Tian WM, Xu QY, Cui FZ, Zhang J, Lu Q, et al. The enhancement of cell adherence and inducement of neurite outgrowth of dorsal root ganglia co-cultured with hyaluronic acid hydrogels modified with Nogo-66 receptor antagonist in vitro. Neuroscience. 2006;137(2):519–29.
Johe KK, Hazel TG, T Muller, Dugich DMM, McKay RD. Single factors direct the differentiation of stem cells from the fetal and the adult central nervous system. Genes. 1996; 3129–40.
Pardridge WM, Kang YS, Buciak JL. Transport of human recombinant brain-derived neurotrophic factor (BDNF) through the rat blood-brain barrier in vivo using vector-mediated peptide drug delivery. Pharma Res. 1994;11:738–46.
Pardridge WM, Wu D, Sakane T. Combined use of carboxyldirected protein pegylation and vector-mediated blood-brain barrier drug delivery system optimizes brain uptake of brain-derived neurotrophic factor following intravenous administration. Pharma Res. 1998;15:576–82.
Amico B, Mark H, Doris D. Hyaluronic acid and hyaluronic acid-binding proteins in brain extracellular matrix. Anat Embryol. 1993;188:419–33.
Yong JR, Zi YZ, Fu ZC, Ying W, Jun PZ, Qun YX. Hyaluronic acid/polylysine hydrogel as a transfer system for transplantation of neural stem cells. J Bioact Compat Polym. 2009;24:56–62.
Huang EJ, Reichardt LF. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci. 2001;24:677–736.
Islam O, Loo TX, Heese K. Brain-derived neurotrophic factor (BDNF) has proliferative effects on neural stem cells through the truncated TRK-B receptor, MAP kinase, AKT, and STAT-3 signaling pathways. Curr Neurovasc Res. 2009;6(1):42–53.
Schänzer A, Wachs FP, Wilhelm D, Acker T, Cooper-Kuhn C, Beck H, et al. Direct stimulation of adult neural stem cells in vitro and neurogenesis in vivo by vascular endothelial growth factor. Brain Pathol. 2004;14(3):237–48.
Abe K. Therapeutic potential of neurotrophic factors and neural stem cells against Ischemic brain injury. J Cereb Blood Flow Metab. 2000;20(10):1393–408.
Qin S, Yue W, Erzsebet K, Gang L, Shu MC, Susan KG, et al. Adult SVZ stem cells lie in a vascular niche: a quantitative analysis of niche cell-cell interactions. Cell Stem Cell. 2008;3:289–300.
Tang J, Hua Y, Su J, Zhang P, Zhu X, Wu L, et al. Expression of VEGF and neural repair after alprostadil treatment in a rat model of sciatic nerve crush injury. Neurol India. 2009;57:387–94.
Taoufik E, Petit E, Divoux D, Tseveleki V, Mengozzi M, Roberts ML. TNF receptor I sensitizes neurons to erythropoietin- and VEGF-mediated neuroprotection after ischemic and excitotoxic injury. Proc Natl Acad Sci. 2008;105:6185–90.
Ke C, Yin ZL, William SK. Three-dimensional polymer scaffolds for high throughput cell-based assay systems. Biomaterials. 2008;29(18):2802–12.
ACKNOWLEDGMENTS
We thank the NSFC (No.30670656, No.50973052, No.30911120495, No.81070977) and the National Basic Research Program of China (973 Program) (No.2005CB623905, No.2010CB606205) for support of funding.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Wang, Y., Wei, Y.T., Zu, Z.H. et al. Combination of Hyaluronic Acid Hydrogel Scaffold and PLGA Microspheres for Supporting Survival of Neural Stem Cells. Pharm Res 28, 1406–1414 (2011). https://doi.org/10.1007/s11095-011-0452-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-011-0452-3